SecurityCOCP / Cocrystal Pharma, Inc. (19188J102)
IndustryPharmaceutical Preparations
Institutional Owners4
Institutional Shares2,364,597 - 0.32%
Common Stock Shares Outstanding728,239,000 shares (as of 2017-09-30)
Institutional Value$ 24,000 USD

Institutional Stock Ownership and Shareholders

Cocrystal Pharma, Inc. (NASDAQ:COCP) has 4 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,364,597 shares. Largest shareholders include Opko Health, Inc., MAI Capital Management, Glenmede Trust Co Na, and Highlander Capital Management, LLC.

Cocrystal Pharma, Inc. (NASDAQ:COCP) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

File DateFormInvestor Opt Prev Shares Current Shares Change
Prev Value (x$1000) Current Value (x$1000) Change
2018-02-15 13F-HR GLENMEDE TRUST CO NA 25,000 5
2018-02-02 SC 13G/A Opko Health, Inc. 63,634,259 2,244,597 -96.47
2018-01-30 13F-HR MAI Capital Management 85,000 85,000 0.00 23 17 -26.09
2018-02-13 13F-HR Highlander Capital Management, LLC 20,000 10,000 -50.00 5 2 -60.00

CUSIP: 19188J102